BRYUINS Maike Jokhanna,EDENS Lyuppo,NAN Maria Khelena
申请号：
RU20160128070
公开号：
RU2671832(C1)
申请日:
2014.12.11
申请国别(地区):
俄罗斯
年份:
2018
代理人:
摘要：
FIELD: medicine; pharmaceuticals.SUBSTANCE: invention relates to the pharmaceutical industry and is a dietary supplement containing Aspergillus niger aspergilloglutamic peptidase, prolyl-endopeptidase and dietary suitable excipients, as well as a pharmaceutical composition for the treatment of gluten intolerance in humans, containing Aspergillus niger aspergilloglutamic peptidase, prolyl endopeptidase and pharmaceutically suitable excipients.EFFECT: invention provides for the hydrolysis of alpha-amylase/trypsin inhibitors in order to treat diseases associated with innate immune response in humans, or enables to slow down the manifestations of these diseases.20 cl, 6 ex, 2 tbl, 5 dwg
